| Literature DB >> 19101701 |
Kazuhiro Haginoya1, Shigeaki Miyabayashi, Masahiro Kikuchi, Akira Kojima, Katsuya Yamamoto, Kiyoshi Omura, Mitsugu Uematsu, Naomi Hino-Fukuyo, Soichiro Tanaka, Shigeru Tsuchiya.
Abstract
Respiratory failure can be the direct cause of death in patients with Leigh syndrome. Unfortunately, no effective treatment strategy is available. Here, we report successful treatment of a patient with Leigh syndrome using idebenone, a derivative of coenzyme Q-10. The patient's brainstem function, especially respiratory function, improved after idebenone treatment. Idebenone may be worth trying in patients with Leigh syndrome.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19101701 DOI: 10.1016/j.jns.2008.11.008
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181